Provider Notices & Telehealth
- Document control
- MP-PROV-BETA-1.0
- Effective date
- August 19, 2026 (private beta)
- Last updated
- August 19, 2026
- Clinical provider
- Beluga Health, P.A. and affiliated licensed clinicians identified before care
This page explains the roles of Malibu Protocol and the independent healthcare professionals involved in care. It does not replace the provider's informed consent, Notice of Privacy Practices, or treatment-specific clinical materials.
Emergency care
Malibu Protocol and asynchronous telehealth messaging are not emergency services and are not monitored continuously. For a medical or psychiatric emergency, call 911 or go to the nearest emergency department. In the United States, call or text 988 for the Suicide & Crisis Lifeline.
Malibu Protocol's role
Westward Science LLC, d/b/a Malibu Protocol, operates the technology and administrative platform. Malibu Protocol may provide account, intake, customer-support, payment, and fulfillment-coordination services. Malibu Protocol is not a medical practice, prescribing clinician, pharmacy, or laboratory and does not make clinical or pharmacy-practice decisions.
The medical provider's role
Clinical services are provided by licensed professionals affiliated with Beluga Health, P.A. or the affiliated medical practice identified to you before care. Your clinician must be appropriately licensed for the state where you are physically located when care is delivered.
The medical practice and clinician independently control evaluation, medical necessity, diagnosis, treatment, prescribing, dosage, laboratory requirements, follow-up, referral, medical records, and pharmacy routing. Neither completing an assessment nor paying guarantees that a clinician will accept a case, recommend a treatment, or issue a prescription.
Before care begins, your clinical flow shows the medical practice responsible for the encounter, clinician identity and credentials as required, applicable state license and complaint information, how to ask the prescriber a question, how to request medical records, the Provider Group's Notice of Privacy Practices, and the current telehealth informed consent.
Telehealth
Telehealth may include asynchronous questionnaires and secure store-and-forward communications as well as SMS/MMS, telephone, audio/video, images, laboratory information, and other methods allowed for the patient's state and situation. The clinician decides whether telehealth is appropriate and may require video, telephone, laboratory testing, records, an in-person examination, or referral.
Telehealth has potential benefits, including convenience and access, and potential limitations, including incomplete information, technology or communication failures, delayed response, privacy risk, and the possibility that remote care is insufficient. These and state-specific rights are described in the Provider Group's authoritative telehealth informed consent.
Required provider documents
Telemedicine Informed Consent
Your clinician's telehealth informed consent is presented in the clinical flow before care begins. Review and accept that document there — not through a generic website Terms checkbox. The Provider Group controls the authoritative version, including emergency and crisis instructions.
Provider privacy notices
The Provider Group's Notice of Privacy Practices and related privacy materials are presented or linked in the clinical flow. They are separate from Malibu Protocol's Privacy Policy and control how the medical practice uses and discloses medical information.
Pharmacy and medication
If a clinician issues a prescription, an independent licensed pharmacy chosen or approved through the clinical workflow dispenses it. Malibu Protocol does not compound, manufacture, prescribe, or dispense medication.
Before fulfillment, you can identify the dispensing pharmacy and its contact information in your order or care materials. The pharmacy label and pharmacist are the authoritative sources for ingredients, concentration, instructions, storage, discard date, and pharmacy questions.
Compounded medications
Compounded medications are not FDA approved, and the FDA does not review a compounded formulation for safety, effectiveness, or quality before marketing. They are not FDA-approved generics and must not be presented as the same as or equivalent to an FDA-approved branded drug. A clinician determines whether a compounded medication is appropriate for an individual patient.
Questions and complaints
- Clinical question or side effect: use the care channel identified by the clinician and Provider Group. Do not rely on general customer-support email for clinical issues.
- Suspected emergency: call 911; call or text 988 for a suicide or mental-health crisis in the United States.
- Provider complaint or medical-board contact: use the method shown in your clinical materials or the Provider Group's Notice of Privacy Practices.
- Medical records or provider privacy: use the contact in the Provider Group's Notice of Privacy Practices.
- Pharmacy question: use the contact on the prescription label or pharmacy fulfillment notice.
- Malibu account, payment, or fulfillment support: care@malibuprotocol.com.